Search
for
Sort by
Research 91–120 of 652
- Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodology
- Cardiovascular profile of pharmacological agents used for the management of polycystic ovary syndrome
- Hormone replacement therapy and COVID-19 outcomes in solid organ transplant recipients compared with the general population
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Efficacy and safety of ritlecitinib in Asian patients with alopecia areata: A subgroup analysis of the ALLEGRO phase 2b/3 trial
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape
- Cardiovascular effects of hormone therapy for prostate cancer
- Inflammation in androgenetic alopecia and hair loss: linking neurosciences-endocrinology-dermatology
- Exploring novel management options for alopecia areata
- New oral anticoagulants and their reversal agents
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Case 2-2022: An Adolescent Male in Cardiac Arrest 3 Days After Liver Transplantation for End-Stage Liver Disease
- Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study
- Alopecia in three women of southeast asian descent with chronic renal failure: Possible association with erythropoietin use
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Hypersensitivity Reactions to Anticoagulant Drugs
- Non-hemorrhage-related adverse effects of rivaroxaban
- A case of widespread actinic granuloma with associated drug-induced lupus erythematosus
- Cytostatics and immunosuppressive drugs
- Generalised cutaneous necrosis: a complication of low-molecular-weight heparin
- Prescription Appropriateness of Cyproterone Acetate/Ethinylestradiol in Primary Care: A Population-Based Study in Italy
- Update: baricitinib for alopecia areata
- Eczema-like, erythematous, infiltrated plaques: A common side effect of subcutaneous heparin therapy
- PCOS and Obesity: Contraception Challenges
- ANIFROLUMAB IN THE MANAGEMENT OF LUPUS HEADACHES: A CASE REPORT
- ASSOCIATION OF SYSTEMIC LUPUS ERYTHEMATOSUS AND CHRONIC GRANULOMATOUS DISEASE IN ADULTS: REPORT OF 2 CASES